…
comment: The repository administrator has not yet configured an RDF license.
primary topic: HELMINTH INFECTIONS: IMMUNOLOGICAL EVASION AND METABOLIC EXPLOITATION — PATHOGENESIS AND NOVEL THERAPEUTIC TARGETS

HELMINTH INFECTIONS: IMMUNOLOGICAL EVASION AND METABOLIC EXPLOITATION — PATHOGENESIS AND NOVEL THERAPEUTIC TARGETS
type: AcademicArticle
type: Article
abstract: This systematic review aims to decode the mechanisms of metabolic exploitation and immune evasion employed by helminths that disrupt host homeostasis, as well as their objective clinical consequences. The study was conducted based on sources selected from international databases such as Scopus, Web of Science, and PubMed, covering the last decade (2016–2026) and complying with PRISMA standards. The analysis demonstrates that helminths activate anaerobic cascades (notably phosphoenolpyruvate carboxykinase, PEPCK) to utilize host energy substrates and release cytotoxic metabolites into the tissue microenvironment. In parallel, parasite-derived excretory-secretory (ES) mediators polarize macrophages toward a pathological M2 phenotype and artificially shift the Th2/Treg tolerance axis into a dominant state. Such biochemical interference results in pronounced oxidative stress, granulomatous fibrosis of tissues, and functional decompensation of organs.
date: 2026-05-30
status: published
author list: authors
type: EPrint
type: ArticleEPrint
is part of: repository

SIR Publishers
type: Organization

JOURNAL OF APPLIED MEDICAL SCIENCES
type: Collection

Anorxol Kungirotova
type: Person
given name: Anorxol
family name: Kungirotova

Azizbek Ashurov
type: Person
given name: Azizbek
family name: Ashurov

HTML Summary of #51710 HELMINTH INFECTIONS: IMMUNOLOGICAL EVASION AND METABOLIC EXPLOITATION — PATHOGENESIS AND NOVEL THERAPEUTIC TARGETS
format: text/html
primary topic: HELMINTH INFECTIONS: IMMUNOLOGICAL EVASION AND METABOLIC EXPLOITATION — PATHOGENESIS AND NOVEL THERAPEUTIC TARGETS